Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingObservational

Biology of Young Lung Cancer Study: The YOUNG LUNG Study

NCT ID: NCT05265429Sponsor: Dana-Farber Cancer InstituteLast updated: 2025-10-29

Summary

The purpose of this research study is to learn more about lung cancer (NSCLC or SCLC) diagnosed in adults at ages 45 or younger.

Detailed description

This research study looks to enroll as many people diagnosed with lung cancer at 45 years old or younger in order to: * Better understand causes of lung cancer in individuals 45 years old and younger, which is a rare disease * Better estimate lung cancer risks and potential risk factors for lung cancer in individuals 45 years old and younger * Examine tumor (somatic) or normal (germline) genetic changes that may be shared among young lung cancer patients * Improve opportunities for screening and treatment of lung cancer in individuals 45 years old and younger Study procedures will include: * Collecting information from participants' medical record and two (2) short questionnaires * Collecting blood and/or saliva samples * Collecting tumor tissue samples (optional) It is expected that about 500 people will take part in this research study. Participants will be in this study until it closes or the participant withdraws consent.

Arms & interventions

  • GeneticData and Specimen Collection

    * Provide research team access to relevant medical records * Answer two (2) short questionnaires at time of consent * Provide up to 5 tubes (37 ml) of blood at or near the time of consent, and/or saliva sample * Consider consenting to other optional parts of the research such as: * Providing additional blood or tissue samples in the future (optional) * Providing permission for obtainment of stored tissue specimens from lung cancer surgeries or biopsies from the pathology departments where they have been stored (optional)

Outcome measures

Primary

  • Repository of specimens and data

    Prospective registry of young lung cancer specimens for exploratory tumor and germline genomics, transcriptomics/proteomics, and future biomarker study.

    Time frame: 5 years or study closure

Secondary

  • Number of patients with targetable somatic alterations in known oncogenic driver genes

    Time frame: 5 years or study closure

  • Number of patients with predicted oncogenic alterations in unknown driver genes

    Time frame: 5 years or study closure

  • Number of patients with pathogenic or likely pathogenic germline alterations in known cancer predisposition genes

    Time frame: 5 years or study closure

Eligibility criteria

Sex: AllAge: 15 Years and olderHealthy volunteers: No
Inclusion Criteria: * Age 45 and under at lung cancer diagnosis * Pathologically confirmed bronchogenic lung carcinoma (NSCLC or SCLC of any stage) at any treatment time point * Provision of written informed consent * Willingness to undergo no more than two (2) peripheral blood draws in a four (4) week period, with no more than 50 ml peripheral blood collected over eight (8) weeks * Individuals under age 18 are eligible for study if they meet defined criteria; in addition, consent for participation must be given by a legal guardian or parent Exclusion Criteria: * Individuals who decline to sign consent * Individuals who are unable to give consent or assent and are without a designated healthcare proxy * Compromise of patient diagnosis or staging if tissue is used for research

Study locations (4)

Massachusetts General Hospital

Boston, Massachusetts, 02114

Recruiting
Jessica Line, MD · Contact
Jessica Lin, MD · Principal Investigator

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02115

Not Yet Recruiting
Daniel Costa, MD PhD · Contact
Daniel Costa, MD PhD · Principal Investigator

Brigham and Women's Hospital

Boston, Massachusetts, 02115

Not Yet Recruiting
Pasi A Janne, MD, PhD · Contact
Pasi A Janne, MD, PhD · Principal Investigator

Dana-Farber Cancer Institute

Boston, Massachusetts, 02115

Recruiting
Pasi A Janne, MD, PhD · Contact
Pasi A Janne, MD, PhD · Principal Investigator